Advertisement

Supply Chain



The leading tactics to combat supply chain disruptions are confirming vendor-approved product alternatives and stockpiling, according to a Kaufman Hall report published Oct. 24. 

The CDC is urging clinicians to prioritize 100 milligram doses of a new respiratory syncytial virus drug for infants at highest risk of severe disease amid limited supply. 

Demand for the first FDA-approved respiratory syncytial virus drug for children is surpassing what the drugmaker expected, and the CDC has paused orders.

The FDA classified about 1,460 Hamilton Medical ventilators in a Class I recall, part of a voluntary correction, because electrolyte fluid might leak onto the device's control board. 

Advertisement

Most Read

Advertisement
Advertisement